Compounding Pharmacy · Southlake, TX · 503B

FarmaKeio Outsourcing Review

FarmaKeio Outsourcing is the FDA-registered 503B arm of the FarmaKeio Pharmacy Network, a Texas-based custom compounding operation that produces sterile formulations including semaglutide and tirzepatide combinations. FarmaKeio is licensed in 49 states plus Puerto Rico and the U.S. Virgin Islands and is a lead plaintiff, alongside the Outsourcing Facilities Association, in litigation challenging the FDA's removal of tirzepatide from the drug shortage list.

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

503BFDA Registered 503B
Location: Southlake, TX
Website: farmakeio.com
States licensed: 0
7.0
★★★★☆3.5/5

Editorial score · methodology

Top-Rated GLP-1 Partners

Not sourced from FarmaKeio Outsourcing — these are our highest-scored vetted telehealth partners for compounded GLP-1s, if you'd rather start with a provider we've walked through end to end.

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

No insurance needed · HSA/FSA eligible · vetted by our editors

7.8

Care Bare Rx

LGBTQ+-inclusive compounded GLP-1 telehealth

Starting price: $199/mo

Get started →Read review Care Bare Rx →
8.2

Enhance MD

Lab-monitored compounded GLP-1 with mandatory video visit

Starting price: $112/mo

Get started →Read review Enhance MD →
7.1

MEDVi

Switching between compounded and brand-name GLP-1 through one provider

Starting price: $179/mo

Get started →Read review MEDVi →
7.3

Liv Body

Compounded GLP-1 paired with a muscle-preservation supplement stack

Starting price: $99/mo

Get started →Read review Liv Body →

Certifications & Compliance

All sterile compounding pharmacies in the United States are required to follow United States Pharmacopeia General Chapter <797> sterile compounding standards[4], with finished preparations evaluated against USP <71> sterility testing[5] and USP <85> bacterial endotoxin testing[6] as appropriate for the product type.

FDA Registered 503B
Registered directly with the FDA as a 503B outsourcing facility. Subject to FDA inspection and required to follow cGMP standards.

Drugs Produced

Compounding pharmacies' ability to produce semaglutide or tirzepatide depends on the FDA Drug Shortage List status for each reference product; compounding eligibility can change when a drug moves on or off the shortage list[7].

Semaglutide
Compounded semaglutide produced
Tirzepatide
Compounded tirzepatide produced

States Licensed

FarmaKeio Outsourcing has not published a state-by-state licensure list. Verify licensure for your state directly with your state board of pharmacy before filling a prescription here.

Regulatory Actions

No public FDA enforcement actions or recalls are on file in our records for FarmaKeio Outsourcing. Regulatory status can change — verify with the FDA and your state board of pharmacy before relying on this information.

Weight Loss Rankings Score Breakdown

Accreditation & Compliance6/10
Regulatory Standing9/10
State Coverage0/10
GLP-1 Production10/10
Track Record5/10

Scores are independently researched. See our methodology for details.

Medium confidence · Last verified 2026-06-04 via manual · How we verify provider data

Frequently Asked Questions

FarmaKeio Outsourcing is a 503B compounding pharmacy based in Southlake, TX. It operates under state board of pharmacy licensure. We are not aware of any recent public FDA enforcement actions against the pharmacy, though compounding pharmacy regulatory history can change. Always verify current status with your state board of pharmacy.
FarmaKeio Outsourcing is headquartered in Southlake, TX. The pharmacy is licensed to ship to 0 US states.
FarmaKeio Outsourcing produces compounded semaglutide and compounded tirzepatide in addition to other compounded preparations. As a 503B pharmacy, it can batch-produce sterile compounds under FDA cGMP standards.
503A pharmacies prepare compounded medications for individual patients in response to specific prescriptions and are regulated primarily by state boards of pharmacy under USP <797> sterile compounding standards. 503B outsourcing facilities register directly with the FDA, follow current Good Manufacturing Practices (cGMP), and can produce compounded medications in larger batches without patient-specific prescriptions. 503B facilities are subject to FDA inspection.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

See Top Semaglutide ProvidersAll Pharmacies
Sources & methodology — as of September 2026
  1. 1.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  2. 2.FDA — 503B Outsourcing Facility Registration and Requirements— U.S. Food & Drug Administration.
  3. 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  4. 4.USP General Chapter <797> — Pharmaceutical Compounding: Sterile Preparations— United States Pharmacopeia.
  5. 5.USP General Chapter <71> — Sterility Tests— United States Pharmacopeia.
  6. 6.USP General Chapter <85> — Bacterial Endotoxins Test— United States Pharmacopeia.
  7. 7.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.